End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
0.71 MYR +4.41% Intraday chart for UMediC Group +10.08% +0.71%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UMediC Group's Profit Slips in Fiscal Q2; Shares Rise 3% MT
UMediC Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
UMediC's Profit Edges Down in Fiscal Q1 MT
UMediC Group Berhad Reports Earnings Results for the First Quarter Ended October 31, 2023 CI
UMedic Group Berhad Announces Resignation of Lau Chee Kheong as Non Independent and Non Executive Non Executive Director CI
UMediC Group Berhad Appoints Dato Dr. Teh Keng Hwang as Independent and Non-Executive Director CI
UMediC Group's Profit, Revenue Jump in Fiscal Q4 MT
UMediC Group Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended July 31, 2023 CI
56,086,500 Ordinary Shares of UMediC Group Berhad are subject to a Lock-Up Agreement Ending on 26-JUL-2023. CI
UWC, Two Others to Buy Equity Interest in Meta Healthcare Units MT
UMediC Group's Profit, Revenue Jump in Fiscal Q3 MT
UMediC Group Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
UMediC Group Books Profit in Fiscal Q2 MT
UMediC Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
UMediC Group Berhad Announces Appointment of Ng Sze Hui as Executive Alternate Director CI
UMediC Group Berhad Announces Cessation of Office of Dr Ng Chin Liang as Non Independent and Non Executive Alternate Director CI
82,626,142 Ordinary Shares of UMediC Group Berhad are subject to a Lock-Up Agreement Ending on 26-JAN-2023. CI
UMediC Logs Profit in Fiscal Q1 MT
UMediC Group Berhad Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
UMediC Group Books Profit in Fiscal Q4 MT
UMediC Group Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended July 31, 2022 CI
UMediC Group Berhad has completed an IPO in the amount of MYR 31.111776 million. CI
UMediC Group Berhad Reports Earnings Results for the Full Year Ended July 31, 2021 CI
Chart UMediC Group
More charts
UMediC Group Berhad is a Malaysia-based investment holding company. The Company operates through two segments: Marketing and distribution and Manufacturing. Marketing and distribution segment is engaged in the marketing and distribution of medical devices as well as the provision of after sales service. Manufacturing segment is engaged in the developing, manufacturing and marketing of medical consumables, namely HydroX series prefilled humidifiers and AirdroX series inhaler spacers. The Company, through its subsidiaries, is principally involved in marketing, distribution, and manufacturing of medical devices as well as the provision of aftersales service. Its products include Hospital Furniture, Life-Support Solution, MR Compatible Monitoring Solution, Oxygen Therapy & Suction Solution, Patient Monitoring System, Resuscitation Care, Ultrasound Solution, Women & Child Care, Anesthesia Solution. Its services include clinical training on equipment, equipment pre-checks, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.71 MYR
Average target price
0.955 MYR
Spread / Average Target
+34.51%
Consensus

Annual profits - Rate of surprise